In 2023, the U.S. healthcare market was valued at $4.9 trillion, representing 17.6% of GDP, with significant contributions from various segments including hospitals and pharmaceuticals. The Personal Injury sector, valued at approximately $59.9 billion and recording 39.6 million cases annually, is projected to grow at a rate of 6.4% per year, driven by factors such as aging population, advancements in medical technology and increasing chronic diseases highlighting emerging opportunities in both healthcare and legal services.

Medical providers—ranging from doctors and hospitals to clinics—often have valuable receivables for assessment. Our experienced brokers and subsidiary meticulously evaluate these receivables using a stringent set of criteria, ensuring only the most promising cases are accepted—typically, only 1 in 5 makes the cut. Each receivable is safeguarded by a legally binding lien, providing additional security and peace of mind for our clients. Our rigorous evaluation process ensures the receivables are reliable financial assets.

Incorporating medical receivables into your investment portfolio not only enhances diversification but also provides a stable source of competitive returns with a proven low-risk profile. These assets generate consistent cash flow while mitigating volatility, making them an essential component for investors seeking stability and growth in today’s market. Seize the opportunity to strengthen your portfolio with an investment that stands resilient against economic fluctuations.

Investing in medical receivables is a powerful opportunity, allowing $1 to acquire $3 in diversified assets across various treatment types and insurers. This strategy enhances liquidity and reduces risk through a balanced mix of categories such as MRI, pain management, pharmaceuticals and physiotherapy. Notably, these assets are largely uncorrelated with traditional markets, making them an attractive addition to any portfolio for sustained financial growth and stability.